<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33791817</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1435-1544</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Herzschrittmachertherapie &amp; Elektrophysiologie</Title>
          <ISOAbbreviation>Herzschrittmacherther Elektrophysiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ECG and arrhythmias in peripartum cardiomyopathy.</ArticleTitle>
        <Pagination>
          <StartPage>207</StartPage>
          <EndPage>213</EndPage>
          <MedlinePgn>207-213</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00399-021-00760-9</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy (PPCM) is a rare but life-threatening heart disease, with onset in the last month of pregnancy or in the first months after delivery. Extensive studies on the burden of supraventricular and ventricular arrhythmias are lacking. Patients with PPCM present with electrocardiographic findings typical in acute heart failure. Management of arrhythmias in PPCM depends on the severity and the onset (during pregnancy or after delivery). Studies on the use of the wearable cardioverter-defibrillator in patients with PPCM show a substantial burden of ventricular tachyarrhythmias and sudden death in patients with severely reduced left ventricular function. The aim of the present article is to summarize actual knowledge on electrocardiogram findings, arrhythmias, and sudden cardiac death in patients with PPCM.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Duncker</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. duncker.david@mh-hannover.de.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pfeffer</LastName>
            <ForeName>Tobias J</ForeName>
            <Initials>TJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bauersachs</LastName>
            <ForeName>Johann</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Veltmann</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <VernacularTitle>EKG und Arrhythmien bei Peripartumkardiomyopathie.</VernacularTitle>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>31</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Herzschrittmacherther Elektrophysiol</MedlineTA>
        <NlmUniqueID>9425873</NlmUniqueID>
        <ISSNLinking>0938-7412</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="N">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <OtherAbstract Type="Publisher" Language="ger">
        <AbstractText>Die Peripartumkardiomyopathie (PPCM) ist eine seltene, aber lebensbedrohliche Herzerkrankung, die in den letzten Schwangerschaftsmonaten oder den ersten Monaten nach der Entbindung auftritt. Detaillierte Studien zur Arrhythmielast durch supraventrikuläre und ventrikuläre Arrhythmien bei PPCM liegen nicht vor. Patientinnen mit PPCM weisen die typischen EKG-Befunde einer akuten Herzinsuffizienz auf. Die Behandlung von Arrhythmien bei PPCM hängt von der Schwere und vom Zeitpunkt des Auftretens – während der Schwangerschaft oder nach der Entbindung – ab. Studien mit tragbaren Defibrillatoren bei Patientinnen mit PPCM konnten relevante ventrikuläre Tachyarrhythmien und plötzlichen Herztod bei Patientinnen mit schwer eingeschränkter linksventrikulärer Funktion nachweisen. Ziel der vorliegenden Übersichtsarbeit ist es, die aktuelle Datenlage zu EKG, Arrhythmien und plötzlichem Herztod bei Patientinnen mit PPCM zusammenzufassen.</AbstractText>
      </OtherAbstract>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PPCM</Keyword>
        <Keyword MajorTopicYN="N">Pregnancy</Keyword>
        <Keyword MajorTopicYN="N">Reduced left ventricular function</Keyword>
        <Keyword MajorTopicYN="N">Sudden cardiac death</Keyword>
        <Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33791817</ArticleId>
        <ArticleId IdType="doi">10.1007/s00399-021-00760-9</ArticleId>
        <ArticleId IdType="pii">10.1007/s00399-021-00760-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096–1105. https://doi.org/10.1002/ejhf.586</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.586</ArticleId>
            <ArticleId IdType="pubmed">27338866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bauersachs J, König T, van der Meer P et al (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 21:827–843. https://doi.org/10.1002/ejhf.1493</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1493</ArticleId>
            <ArticleId IdType="pubmed">31243866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeBenedetti Zunino ME, Schuger C, Lahiri M (2014) High rate of ventricular arrhythmias in women with peripartum cardiomyopathy and implanted cardioverter defibrillators. J Am Coll Cardiol 63:A313. https://doi.org/10.1016/S0735-1097(14)60313-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0735-1097(14)60313-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diao M, Diop IB, Kane A et al (2004) Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss 97:25–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15002707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duncker D, Haghikia A, König T et al (2014) Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail 16:1331–1336. https://doi.org/10.1002/ejhf.188</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.188</ArticleId>
            <ArticleId IdType="pubmed">25371320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duncker D, Westenfeld R, Konrad T et al (2017) Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis. Clin Res Cardiol 12:767–768. https://doi.org/10.1007/s00392-017-1090-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00392-017-1090-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekizler FA, Cay S, Kafes H et al (2019) The prognostic value of positive T wave in lead aVR: a novel marker of adverse cardiac outcomes in peripartum cardiomyopathy. Ann Noninvasive Electrocardiol 24:e12631. https://doi.org/10.1111/anec.12631</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/anec.12631</ArticleId>
            <ArticleId IdType="pubmed">30653267</ArticleId>
            <ArticleId IdType="pmc">6931550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ersbøll AS, Johansen M, Damm P et al (2017) Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 19:1712–1720. https://doi.org/10.1002/ejhf.882</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.882</ArticleId>
            <ArticleId IdType="pubmed">28597481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goland S, Modi K, Bitar F et al (2009) Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645–650. https://doi.org/10.1016/j.cardfail.2009.03.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardfail.2009.03.008</ArticleId>
            <ArticleId IdType="pubmed">19786252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Berliner D et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38:2671–2679. https://doi.org/10.1093/eurheartj/ehx355</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehx355</ArticleId>
            <ArticleId IdType="pubmed">28934837</ArticleId>
            <ArticleId IdType="pmc">5837241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J (2015) Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36:1090–1097. https://doi.org/10.1093/eurheartj/ehv009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehv009</ArticleId>
            <ArticleId IdType="pubmed">25636745</ArticleId>
            <ArticleId IdType="pmc">4422973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Kaminski K, Podewski E et al (2007) A cathepsin D‑cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600. https://doi.org/10.1016/j.cell.2006.12.036</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2006.12.036</ArticleId>
            <ArticleId IdType="pubmed">17289576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoevelmann J, Viljoen CA, Manning K et al (2019) The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy. Int J Cardiol 276:177–184. https://doi.org/10.1016/j.ijcard.2018.11.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2018.11.008</ArticleId>
            <ArticleId IdType="pubmed">30497895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honigberg MC, Elkayam U, Rajagopalan N et al (2019) Electrocardiographic findings in peripartum cardiomyopathy. Clin Cardiol 42:524–529. https://doi.org/10.1002/clc.23171</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/clc.23171</ArticleId>
            <ArticleId IdType="pubmed">30843220</ArticleId>
            <ArticleId IdType="pmc">6522992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karaye KM, Lindmark K, Henein MY (2016) Electrocardiographic predictors of peripartum cardiomyopathy. Cardiovasc J Afr 27:66–70. https://doi.org/10.5830/CVJA-2015-092</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5830/CVJA-2015-092</ArticleId>
            <ArticleId IdType="pubmed">27213852</ArticleId>
            <ArticleId IdType="pmc">4928165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krexi D, Sheppard MN (2017) Cardiovascular causes of maternal sudden death. Sudden arrhythmic death syndrome is leading cause in UK. Eur J Obstet Gynecol Reprod Biol 212:155–159. https://doi.org/10.1016/j.ejogrb.2017.03.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejogrb.2017.03.006</ArticleId>
            <ArticleId IdType="pubmed">28371698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labidi S, Hilfiker-Kleiner D, Klein G (2011) Left bundle branch block during pregnancy as a sign of imminent peripartum cardiomyopathy. Eur Heart J 32:1076. https://doi.org/10.1093/eurheartj/ehq487</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehq487</ArticleId>
            <ArticleId IdType="pubmed">21228008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laghari AH, Khan AH, Kazmi KA (2013) Peripartum cardiomyopathy: ten year experience at a tertiary care hospital in Pakistan. BMC Res Notes 6:495. https://doi.org/10.1186/1756-0500-6-495</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-0500-6-495</ArticleId>
            <ArticleId IdType="pubmed">24289218</ArticleId>
            <ArticleId IdType="pmc">4222096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallikethi-Reddy S, Akintoye E, Trehan N et al (2017) Burden of arrhythmias in peripartum cardiomyopathy: analysis of 9841 hospitalizations. Int J Cardiol 235:114–117. https://doi.org/10.1016/j.ijcard.2017.02.084</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2017.02.084</ArticleId>
            <ArticleId IdType="pubmed">28268089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mbakwem AC, Bauersachs J, Viljoen C et al (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Fail 97:25. https://doi.org/10.1002/ehf2.13172</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ehf2.13172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ntusi NBA, Badri M, Gumedze F et al (2015) Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic Peripartum Cardiomyopathy. Plos One 10:e133466. https://doi.org/10.1371/journal.pone.0133466</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0133466</ArticleId>
            <ArticleId IdType="pubmed">26252951</ArticleId>
            <ArticleId IdType="pmc">4529210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Opotowsky AR, Siddiqi OK, D’Souza B et al (2012) Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart 98:145–151. https://doi.org/10.1136/heartjnl-2011-300828</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/heartjnl-2011-300828</ArticleId>
            <ArticleId IdType="pubmed">21990383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfeffer TJ, Klüsch V, Duncker D et al (2020) Long-term follow-up of patients with peripartum cardiomyopathy and an implantable cardioverter defibrillator—a multicenter study. Clin Res Cardiol 109:V639. https://doi.org/10.1007/s00392-020-01621-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00392-020-01621-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. https://doi.org/10.1093/eurheartj/ehw128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehw128</ArticleId>
            <ArticleId IdType="pubmed">27206819</ArticleId>
            <ArticleId IdType="pmc">4946749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17:1601–1687. https://doi.org/10.1093/europace/euv319</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/europace/euv319</ArticleId>
            <ArticleId IdType="pubmed">26318695</ArticleId>
            <ArticleId IdType="pmc">26318695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J et al (2018) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 39:3165–3241. https://doi.org/10.1093/eurheartj/ehy340</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehy340</ArticleId>
            <ArticleId IdType="pubmed">30165544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saltzberg MT, Szymkiewicz S, Bianco NR (2012) Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18:21–27. https://doi.org/10.1016/j.cardfail.2011.09.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardfail.2011.09.004</ArticleId>
            <ArticleId IdType="pubmed">22196837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767–778. https://doi.org/10.1093/eurjhf/hfq120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hfq120</ArticleId>
            <ArticleId IdType="pubmed">20675664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Petrie MC, van der Meer P et al (2020) Clinical presentation, management, and 6‑month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J 41:3787–3797. https://doi.org/10.1093/eurheartj/ehaa455</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehaa455</ArticleId>
            <ArticleId IdType="pubmed">32840318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka H, Katsuragi S, Osato K et al (2017) The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991–1992 to 2010–2012. J Cardiol 69:74–78. https://doi.org/10.1016/j.jjcc.2016.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jjcc.2016.01.005</ArticleId>
            <ArticleId IdType="pubmed">26899278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tibazarwa K, Lee G, Mayosi B et al (2012) The 12-lead ECG in peripartum cardiomyopathy. Cardiovasc J Afr 23:322–329. https://doi.org/10.5830/CVJA-2012-006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5830/CVJA-2012-006</ArticleId>
            <ArticleId IdType="pubmed">22337203</ArticleId>
            <ArticleId IdType="pmc">3734749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaidya VR, Arora S, Patel N et al (2017) Burden of Arrhythmia in Pregnancy. Circulation 135:619–621. https://doi.org/10.1161/CIRCULATIONAHA.116.026681</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026681</ArticleId>
            <ArticleId IdType="pubmed">28154000</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
